Metabolic Effects of the Intracellular Regulation of Thyroid Hormone: Old Players, New Concepts by Cicatiello, Ag et al.
MINI REVIEW
published: 11 September 2018
doi: 10.3389/fendo.2018.00474
Frontiers in Endocrinology | www.frontiersin.org 1 September 2018 | Volume 9 | Article 474
Edited by:
Pieter de Lange,
Università degli Studi della Campania
“Luigi Vanvitelli” Caserta, Italy
Reviewed by:
Cheng Han,
Albert Einstein College of Medicine,
United States
Warner Simonides,
VU University Medical Center,
Netherlands
*Correspondence:
Monica Dentice
monica.dentice@unina.it
Specialty section:
This article was submitted to
Thyroid Endocrinology,
a section of the journal
Frontiers in Endocrinology
Received: 04 June 2018
Accepted: 01 August 2018
Published: 11 September 2018
Citation:
Cicatiello AG, Di Girolamo D and
Dentice M (2018) Metabolic Effects of
the Intracellular Regulation of Thyroid
Hormone: Old Players, New
Concepts. Front. Endocrinol. 9:474.
doi: 10.3389/fendo.2018.00474
Metabolic Effects of the Intracellular
Regulation of Thyroid Hormone: Old
Players, New Concepts
Annunziata G. Cicatiello, Daniela Di Girolamo and Monica Dentice*
Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy
Thyroid hormones (THs) are key determinants of cellular metabolism and regulate a
variety of pathways that are involved in the metabolism of carbohydrates, lipids and
proteins in several target tissues. Notably, hyperthyroidism induces a hyper-metabolic
state characterized by increased resting energy expenditure, reduced cholesterol
levels, increased lipolysis and gluconeogenesis followed by weight loss, whereas
hypothyroidism induces a hypo-metabolic state characterized by reduced energy
expenditure, increased cholesterol levels, reduced lipolysis and gluconeogenesis
followed by weight gain. Thyroid hormone is also a key regulator of mitochondria
respiration and biogenesis. Besides mirroring systemic TH concentrations, the
intracellular availability of TH is potently regulated in target cells by a mechanism
of activation/inactivation catalyzed by three seleno-proteins: type 1 and type 2
iodothyronine deiodinase (D1 and D2) that convert the biologically inactive precursor
thyroxine T4 into T3, and type 3 iodothyronine deiodinase (D3) that inactivates TH action.
Thus, the pleiotropic effects of TH can fluctuate among tissues and strictly depend on the
cell-autonomous action of the deiodinases. Here we review the mechanisms of TH action
that mediate metabolic regulation. This review traces the critical impact of peripheral
regulation of TH by the deiodinases on the pathways that regulate energy metabolism
and the balance among energy intake, expenditure and storage in specific target tissues.
Keywords: Thyroid hormone, Deiodinases, energy metabolism, Thyroid hormone receptors, local regulation of
thyroid function
INTRODUCTION
Thyroid hormones (TH) have long been known to regulate energy metabolism (1). Patients
with TH dysfunction often have symptoms of metabolic dysregulation, including fatigue and
weight changes (2). Indeed, pathological excess of THs in humans raises the basal metabolic
rate (BMR) while TH deficiency is accompanied by a decreased BMR (2). TSH and TRH levels
are also critical determinants of whole body energy metabolism. In fact, they exert thyroidal
and non-thyroidal effects and thus integrate signals from nutritional status and the adrenergic
nervous system with a fine regulation of THs production (3). The wide spectrum of THs effects
on body metabolism is exerted mainly by stimulating catabolic and anabolic reactions and by
regulating turnover of fats, carbohydrates and proteins (1). A peculiar feature of TH-dependent
metabolic regulation is the acceleration of the rates of anabolic and catabolic reactions (4). For
instance, TH increases fat mobilization thereby leading to increased concentrations of fatty acids in
plasma as well as to enhanced oxidation of fatty acids. THs stimulate insulin-dependent glucose
uptake, and both gluconeogenesis and glycogenolysis. Therefore, the action of THs culminates
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in promoting futile cycles that contribute significantly to
the increase oxygen consumption seen in thyrotoxicosis
(“hyperthyroidism”). Thyroid hormones also stimulate ion
cycling by altering membrane permeability, the expression of ion
pumps and the characteristics of these pumps (5–8).
The classic endocrine view of TH biology is that THs are
produced and secreted by the thyroid gland for transport to
target tissues. Accordingly, TH concentrations determine the
extent of hormonal regulation and generate downstream effects
in peripheral cells. Classical regulation of the thyroid gland
involves the hypothalamic–pituitary–thyroid axis, whereas low
TH concentrations trigger a negative feedback that results in
the release of both thyroid releasing hormone (TRH) from the
hypothalamus and thyroid stimulating hormone (TSH) from
the pituitary gland (9, 10). However, besides the capacity of
the thyroid gland to produce the correct amount of THs,
the periphery can modify the TH signal in time and space.
Indeed, while plasma concentrations of TH are relatively stable,
tissues can coordinate TH levels through the cell-autonomous
regulation of TH transporters, deiodinases and TH receptors
(11). The iodothyronine deiodinase family of selenoproteins is
constituted by three enzymes, D1, D2, and D3. These enzymes
are present in specific tissues, and regulate TH activation and
inactivation (12). The differential expression of deiodinases
enables close control of T3 and its prohormone, T4, by removing
iodine moieties (“deiodination”) at different sites of the phenolic
or tyrosylic ring of the TH hormones (13). T4 has a long half-
life and is converted to the active form, T3, within cells by
the activating deiodinases (D1 and D2) that catalyze outer ring
deiodination. The third deiodinase, D3, terminates TH action by
inactivating T3 and T4 by removing the iodine at the inner ring
(13). The local regulation of TH at intracellular level enables wide
fluctuations of TH in local tissues and is a powerful tool with
which to modulate TH action without perturbing systemic TH
levels.
The correlation of a Thr92Ala polymorphism in the DIO2
gene, encoding protein D2, with altered glycemic control, obesity
and type 2 diabetes mellitus (T2DM) (14–16), as well as the
association of genetic variants of the DIO1 gene, encoding
protein D1, with insulin resistance (17), reinforces the clinical
relevance of the peripheral T4-to-T3 conversion in metabolic
control.
In this review we summarize the role of the local control of
TH by the deiodinases in the metabolic program of cells in the
context of the tissue-specific impact of deiodination on energy
metabolism, and discuss the effect of local alteration of TH on
the metabolic functions of the body.
METABOLIC ROLE OF TH AND THE
DEIODINASES
Although each cell of the body is virtually a TH target, the TH
signal is differentially integrated in each tissue depending on
the cell-autonomous machinery. Therefore, the action of TH
on whole body metabolism is best evaluated by examining the
specific contribution of TH and itsmodulating enzymes to energy
metabolism in the context of each target tissue. The relative roles
of most components of the TH signaling pathways have been
assessed in mouse models of inducible, tissue-specific activation
or inactivation of deiodinases, receptors and transporters (1).
These studies revealed how different TH-induced processes
contribute to regulating metabolic homeostasis in humans
(Figure 1).
LIVER
There is an intricate relationship between TH metabolism and
liver (1, 18, 19). Thyroid hormones regulate hepatic function by
modulating the basal metabolic rate of hepatocytes; the liver in
turn metabolizes the THs and regulates their systemic endocrine
effects (20). In the liver, TH regulates lipid metabolism mainly
through the T3-TRβ (TH receptor beta) (1), and the downstream
regulation of cholesterol homeostasis (synthesis and eﬄux), bile
acid synthesis and fatty acid metabolism (1). The local control of
TH metabolism in liver is mediated by the expression of all three
deiodinases. D1 is highly expressed in liver, where it contributes
to plasmatic T3 homeostasis and mediates the clearance of rT3
from the circulation (21). D1 expression is highly sensitive to
T3 levels to such an extent that it is an indicator of the thyroid
state of the liver (22). Despite the high D1 levels in the liver,
the intracellular T3 level in hepatocytes is not mediated by D1,
but by the other TH-activating deiodinase, D2 (23). The liver
is the paradigm of spatio-temporal regulated expression of D2
that is transiently turned on in the neonatal mouse liver between
the first and the fifth post-natal day. During this short time,
a peak of hepatic D2 expression occurs and rapidly declines
to background levels (24). This brief peak of D2 produces an
excess of T3 that modifies the methylation and the expression
pattern of thousands of hepatic genes thereby increasing future
susceptibility to diet-induced obesity and liver steatosis (24).
Mouse models of hepatocyte-specific D2 inactivation (Alb-
D2KO) do not undergo this physiological increase of liver T3 at
birth, with a consequent delay in neonatal expression of lipid-
related genes and a phenotype of resistance to obesity and liver
steatosis (24). These fundamental changes during perinatal life
indicate that the thyroid state of specific tissue impacts on whole
body metabolism thereby affecting the phenotype in adult life
(25). Finally, D3 is almost undetectable in the liver of healthy
individuals, but robust re-activation of D3 has been found in
regenerating liver tissue, in certain hepatic tumors and in sera
and liver samples from critically ill humans, thus influencing the
systemic thyroid status (26). These results suggest that D3 plays a
role in the tissue response to injury and in the imbalance of TH
homeostasis commonly observed during critical illness.
PANCREAS
Thyroid hormone plays a critical role in the development,
maturation, and function of pancreatic cells, where T3 is
required for the physiological maturation of pancreatic β-cells to
glucose-stimulated insulin-secreting cells (27). Pancreatic cells
express both TRα and TRβ isoforms and the activated T3-TR
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FIGURE 1 | Metabolic effects of the intracellular regulation of thyroid hormone in different tissues. (A) Liver: Lipid homeostasis is regulated by local T3 level thereby
influencing susceptibility to obesity and liver steatosis. (B) Pancreas: The balance between the deiodinases controls the development and function of β-cells by
enhancing Mafa transcription factor and inducing insulin secretion. (C) Hypothalamus: Local availability of TH regulates feeding behavior and controls energy
expenditure. (D) Skeletal Muscle: Increased T3 levels in skeletal muscle promote the shift from type I to type II fibers, influence regeneration and increase energy
expenditure. (E) BAT: D2-mediated TH activation regulates UCP1 expression and thermogenesis, adipocyte proliferation and differentiation and body weight. (F) WAT:
Local T3 metabolism regulates adipocyte proliferation/differentiation.
complex directly bind to the promoter of islet transcription
factor Mafa thereby resulting in its activation (27, 28). However,
the exact physiological role of TH in glucose homeostasis
remains controversial (29, 30). Although numerous in vitro
and ex vivo studies have demonstrated that T3 mediates
positive effects on β-cell function, exposure to high doses of
TH results in a phenotype of glucose intolerance. Indeed,
hyperthyroidism is associated with glucose intolerance
consequent to decreased insulin secretion (31, 32) and
to stimulation of hepatic gluconeogenesis (33). Probably,
in hyperthyroid conditions, impaired insulin secretion is
not sufficient to suppress high hepatic glucose production.
Accordingly, the prevalence of diabetes mellitus in hyperthyroid
patients is approximately double that of non-affected subjects
(34). In contrast, systemic hypothyroidism is associated
with reduced hepatic gluconeogenesis and enhanced insulin
sensitivity, as demonstrated by the onset of a hypoglycemic
state after an insulin injection (35). While during vertebrate
development, reduced TH levels are important for normal
function and for glucose homeostasis of pancreatic β-cells,
exposure to high TH doses induces apoptosis of pancreatic
β-cells (36). In this context, the TH hormone-inactivating
deiodinase D3 plays a fundamental role in lineage fate decisions
and endocrine cell specification (34). Indeed, studies in D3KO
mice demonstrated that the reduction D3-mediated of TH action
is critical for normal maturation and function of pancreatic β-
cells (34). D3KO mice exhibited a glucose intolerant phenotype
due to impaired glucose-stimulated insulin secretion, reduced
size, and absolute mass of pancreatic islet and β-cells, decreased
insulin content, and reduced expression of key genes involved
in glucose sensing, insulin synthesis, and exocytosis (34). The
pancreatic phenotype of the D3KOmice is proof that attenuation
of TH-signaling via D3 activation is essential for normal
development.
HYPOTHALAMUS
Peripheral TH signals are integrated within the hypothalamus
and processed into coordinated responses to regulate energy
balance. The center for regulation of food intake and of body
weight is the melanocortin system, constituted by three neuronal
populations: the pro-opiomelanocortin (POMC)-expressing
neurons, the neuropeptide Y (NPY) and agouti-related peptide
(AgRP)-co-expressing neurons and the melanocortin 4 receptor
(MC4R)-expressing neurons (37, 38). The POMC neurons
exert an anorexigenic function by activating MC4R neurons,
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which induce a reduction of food intake and increased energy
expenditure. On contrary, NPY/AgRP neurons are the orexigenic
neurons: by antagonizing the action exerted by POMC onMC4R,
they increase food intake and decrease energy expenditure. All
these neurons are sensitive to the TH signal that can either
activate or inhibit melanocortin neurons, and thus, it is not
surprising that local TH metabolism plays a critical role in
appetite and feeding regulation. Changes in central T3 levels
occur in various metabolic conditions (39), for example
elevated T3 levels have been found in the hypothalamus during
fasting (40). Fasting induces alterations in the thyroid state,
namely, a reduction in pituitary D2 levels and liver D1 levels
correlated with low peripheral T3 levels in the presence of
increased hypothalamic D2 activity. The high D2 activity in the
hypothalamus causes an increase of local T3 concentrations,
which in turn activate orexigenic NPY/AgRP neurons and inhibit
anorexigenic POMC neurons, thereby inducing hyperfagia (1).
The molecular mechanism underlying TH-mediated NPY/AgRP
activation resembles that in brown adipose tissue (BAT) in which
T3 increases uncoupling protein 1 (UCP1) activity. In fact,
high T3 levels in the hypothalamus during fasting, consequent
to D2 activation, promote UCP2 expression and stimulate
mitochondrial proliferation in orexigenic NPY/AgRP neurons,
so promoting their activity and stimulating rebound feeding
upon food deprivation. The increase of T3 in the hypothalamus
also causes TRH mRNA suppression (40, 41). Therefore, under
food deprivation, despite a reduction in peripheral TH levels,
there is a localized increase in T3 within the hypothalamus,
which in turn increases orexigenic signals and decreases TRH
production. The hypothalamus probably maintains low TH
levels to preserve energy stores, which would be dissipated in
hyperthyroid condition.
The fundamental role of deiodinases in the regulation of
energy balance in brain has been demonstrated in mouse models
of deiodinases depletion (42). Despite the low TH circulating
levels in adult Dio3−/− mice, their central nervous system is
in a hyperthyroid state (42). The enhanced TH levels alter
the functioning of the hypothalamic circuitries, including the
leptin-melanocortin system, thereby regulating energy balance
and adiposity. In detail, Dio3−/− mice have decreased adiposity,
but an abnormally functioning leptin-melanocortin system
associated with leptin resistance (43). The hypothalamic D2-
mediated T4 to T3 conversion is important for the photoperiodic
response of the gonads (44) in which fine-tuned D2 and D3
expression tightly regulates LH stimulation (45).
SKELETAL MUSCLE
Skeletal muscle represents 40–50% of the total body mass
in humans and is crucial for metabolism, heat generation
and maintenance of posture. TH influences skeletal muscle
contraction, regeneration and metabolism (46). All components
of the TH signaling process, from TR to TH transporters
(MCT8 and MCT10), and D2 and D3, are expressed in the
skeletal muscle of rodents and humans (47). During skeletal
muscle development, D2 is up-regulated, particularly during
the first postnatal days, and decreases at day 30, although
its activity returns to high levels during differentiation of
muscle stem cells (12, 48, 49). In particular, during post-
injury regeneration processes, D2 mRNA is up-regulated to
enable correct myoblast differentiation (50). D2 is a target of
FOXO3, which is a protein involved in myocyte fusion and
metabolism as well as in atrophy and autophagy (12). Loss of
D2 impairs stem cell differentiation and prevents up-regulation
of myogenic transcription factor MyoD thereby increasing the
proliferative potential of muscle stem cells. D2-mediated TH
in skeletal muscle influences also muscle fibers. High TH
levels induce a shift from type I fibers (slow) to type II
fibers (fast), which results in up-regulation of sarcoendoplasmic
reticulum Ca2+ATPase, of glucose transporter 4 (GLUT4) and
of uncoupling protein 3 (UCP3) thereby producing heat and
increasing energy expenditure (51). D2-dependent T3 activation
influences insulin response in skeletal muscle (52). Indeed, D2KO
mice are insulin-resistant, which demonstrates the relevance of
D2 in glucose homeostasis. In humans, a common polymorphism
of the Dio2 gene, the Thr92Ala substitution in protein D2, which
partially impairs enzymatic activity, has been correlated with
insulin resistance and diabetes (53, 54). Furthermore, muscle
fibers respond to cold through TH-related mechanisms, namely
increased glucose uptake, activation of oxidative pathways and
increased mitochondria biogenesis (55, 56). Interestingly, D2 is
up-regulated in muscle after 4 h of cold exposure (57). Moreover,
D2 is up-regulated in response to such metabolic signals as bile
acids and insulin (1, 58) and during exercise under β-adrenergic
stimulus in order to amplify TH signaling and regulate PGC-1α
expression (59, 60). Coordinated D2-D3 expression is required
to fine-tune intracellular TH availability during muscle stem cell
differentiation, and in vivo, during muscle regeneration (47).
While D2 is essential for a correct T3 surge and the subsequent
differentiation of muscle stem cells, D3 fosters muscle stem
cell proliferation by lowering TH availability during the early
phases of the myogenic program (47). This dual regulation is
so critical that D3-depletion in vivo causes massive apoptosis
of proliferating satellite cells and drastically impairs a full
regeneration process. These studies highlight the pivotal role of
the intracellular TH coordination by the deiodinases in muscle
physiology.
BROWN ADIPOSE TISSUE
Brown adipose tissue is characterized by multilocular lipid
droplets and numerous mitochondria, and governs heat
production (61). In fact, BAT is activated in response to a
high fat diet or cold exposure in order to protect the organism
from weight gain and hypothermia. Thyroid hormone critically
influences BAT activity (62). The most obvious metabolic role of
D2 is the regulation of energy expenditure in the BAT of small
mammals, including human newborns. During cold exposure,
the sympathetic nervous system induces D2 expression in brown
adipocytes, thereby promoting local T4-to-T3 conversion, and
activation of the transcription of target genes involved in the
thermogenic program (63). Loss of function of D2 reduces
the level of UCP-1, which is normally up-regulated at RNA
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level by TH. D2 is thus considered a marker of BAT activity
(1, 57). Interestingly, global D2KO mice are resistant to diet-
induced obesity, highly tolerant to glucose, and have a deficit
in respiratory quotient at 22◦C, while at 30◦C they become
more susceptible to obesity and develop intolerance to glucose
(64, 65). T3 regulates the expression of several genes during
adipogenic differentiation, among which GPD, ME, PEPCK, S14,
FAS, and GLUT4 (66, 67). While D2 activity is important during
differentiation, D3 is considered a mitogenic marker in brown
pre-adipocytes. In fact, D3 mRNA and activity are induced by
bFGF and aFGF in proliferating brown pre-adipocytes (68). In
BAT, T3 also accelerates fatty acid oxidation and lipogenesis
through the action of the ACC and ME lipogenic enzymes.
Consequently, D2KOmice have reduced fatty acid oxidation and
lipogenesis (4).
WHITE ADIPOSE TISSUE
The primary function of white adipose tissue (WAT) is to store
energy in the form of single large lipid droplets, although it also
secretes the leptin and adiponectin adipokines. White adipocytes
differ anatomically and physiologically from brown adipocytes.
However, the latter may appear at sites corresponding toWAT, in
a so-called process of WAT “browning” caused by a thermogenic
stimulus, such as prolonged cold exposure (69), or treatment with
β3-adrenergic receptor activators (70). The brown adipocytes in
WAT are often called “inducible,” “beige,” or “brite.” D1 and D2
are barely expressed in epidermal WAT, the adipose tissue that,
contrary to inguinal WAT, is never converted in BAT. All TR
isoforms and the TH transporter MCT8 are expressed in human
subcutaneous adipose tissue (71). D1 expression in epidermal
WAT is only 1% of the D1 found in the liver. Similarly, the
D2 mRNA level is 7% of the D2 in BAT (72). Interestingly,
D1 expression and activity are increased in the subcutaneous
and visceral WAT of obese subjects (71). On the other hand,
D2 is up-regulated in beige/brite adipocytes and its expression
is correlated to increased energy expenditure (73). A high-fat
diet stimulates D1 and leptin expression, while caloric restriction
decreases D1 activity as well as leptin levels, and increases
levels of the leptin mediator SCD-1. Leptin overexpression
increases D1 activity and down-regulates SCD-1 expression (74).
Similar to brown adipocytes, in white adipocytes, D2 plays
an important role in lipogenesis and in the regulation of the
expression of genes related to adipocyte differentiation, while D3
sustains the proliferation of white adipocytes (61). Interestingly,
thyroidectomized mice have an increased level of both D1 and
D2 (72). Moreover, D2 is expressed also in human pre-adipocytes
although its role is unclear (75).
FUTURE DIRECTIONS AND
CONCLUSIONS
Monodeiodination is quantitatively the most important pathway
of TH activation. Within peripheral tissue, multiple pathways
modulate TH availability. These pathways govern the action
and regulation of deiodinase expression, the action of TH
transporters, and the expression and crosstalk of TH receptors
with multiple partners. This intricate network of TH modifiers
increases the sensitivity and the speed of responses to changes
induced in the internal and external environment by the
thyroid signal. The price to be paid for this is an intricate
regulation of each component in time and space. Given the
vast spectrum of metabolic body functions regulated by the
TH signal, the deiodinases represent a powerful tool with
which to modulate cellular metabolism in specific tissues
without perturbing systemic levels of THs. Consequently, the
development of drugs that target deiodinase action is the
next challenge in this field. Extensive work is still required
to delineate the kinetics and regulation of the deiodinase
enzymes in specific tissues to understand the full spectrum of
their biological roles. Thus, pharmacological research is poised
to develop deiodinase modulators aimed at driving specific
metabolic outcomes. Targeting tissue-specific TH actions may
result in novel and safe therapeutic options for metabolic
dysfunctions.
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